- Home
- TACH vs MASS Comparison
TACH vs MASS Comparison
Compare TACH & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACH
- MASS
- Stock Information
- Founded
- TACH 2024
- MASS 2012
- Country
- TACH United States
- MASS United States
- Employees
- TACH N/A
- MASS N/A
- Industry
- TACH
- MASS Medical/Dental Instruments
- Sector
- TACH
- MASS Health Care
- Exchange
- TACH Nasdaq
- MASS Nasdaq
- Market Cap
- TACH 351.2M
- MASS 324.4M
- IPO Year
- TACH 2025
- MASS 2020
- Fundamental
- Price
- TACH $10.19
- MASS $7.88
- Analyst Decision
- TACH
- MASS Strong Buy
- Analyst Count
- TACH 0
- MASS 3
- Target Price
- TACH N/A
- MASS $8.00
- AVG Volume (30 Days)
- TACH 133.6K
- MASS 320.9K
- Earning Date
- TACH 01-01-0001
- MASS 11-10-2025
- Dividend Yield
- TACH N/A
- MASS N/A
- EPS Growth
- TACH N/A
- MASS N/A
- EPS
- TACH 0.19
- MASS N/A
- Revenue
- TACH N/A
- MASS $65,560,000.00
- Revenue This Year
- TACH N/A
- MASS N/A
- Revenue Next Year
- TACH N/A
- MASS $22.29
- P/E Ratio
- TACH $53.35
- MASS N/A
- Revenue Growth
- TACH N/A
- MASS 37.93
- 52 Week Low
- TACH $10.00
- MASS $1.81
- 52 Week High
- TACH $10.38
- MASS $9.34
- Technical
- Relative Strength Index (RSI)
- TACH N/A
- MASS 48.80
- Support Level
- TACH N/A
- MASS $7.88
- Resistance Level
- TACH N/A
- MASS $9.20
- Average True Range (ATR)
- TACH 0.00
- MASS 0.56
- MACD
- TACH 0.00
- MASS -0.14
- Stochastic Oscillator
- TACH 0.00
- MASS 24.10
About TACH Titan Acquisition Corp. Class A Ordinary Shares
Titan Acquisition Corp is a blank check company.
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.